LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
5.35
+0.14 (2.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LENSAR Revenue
In the year 2025, LENSAR had annual revenue of $58.44M with 9.24% growth. LENSAR had revenue of $16.03M in the quarter ending December 31, 2025, a decrease of -4.22%.
Revenue (ttm)
$58.44M
Revenue Growth
+9.24%
P/S Ratio
1.11
Revenue / Employee
$389,567
Employees
150
Market Cap
64.71M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 133.93M |
| Outset Medical | 119.48M |
| Pulmonx | 90.50M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
| InspireMD | 8.98M |
LNSR News
- 4 weeks ago - LENSAR Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
- 6 weeks ago - LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC - GlobeNewsWire
- 2 months ago - LENSAR® Provides Update on Pending Acquisition by Alcon - GlobeNewsWire
- 6 months ago - LENSAR® Reports Third Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 8 months ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 months ago - LENSAR Reports Second Quarter 2025 Results and Provides Business Update - GlobeNewsWire